Home›Stock Screener›Camlin Fine Sciences

Camlin Fine Sciences Share Price Today | Stock Price & Camlin Fine Sciences Share Screener

CAMLINFINE Chemicals & Petrochemicals
Live Share Price NSE
₹71.11
▼ -1.04 (-1.44%)
2026-11-19 00:00:00
Live Share Price BSE
₹71.04
▼ -1.07 (-1.48%)
2026-11-19 00:00:00

As of November 19, 2026, the live Camlin Fine Sciences share price (NSE: CAMLINFINE) is ₹71.11 on NSE and ₹71.04 on BSE, down 1.44% from the previous close, with shares trading between ₹70.50 and ₹72.47 in today's trading session, and a 52-week range of ₹71.11–₹177.37. Track Camlin Fine Sciences networth to gauge the company's total market size. Use the Camlin Fine Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Camlin Fine Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹497 and net income of ₹-30, with EBITDA of ₹4.

Camlin Fine Sciences Market Cap ₹1,440.34 Cr.
CAMLINFINE P/E Ratio (TTM) -103.90
Camlin Fine Sciences P/B Ratio 1.52
EPS (TTM) ₹1.46
Dividend Yield -
Debt to Equity 0.71
CAMLINFINE 52 Week High ₹177.37
Camlin Fine Sciences 52 Week Low ₹71.11
Operating Margin -
Profit Margin -6.04%
CAMLINFINE Revenue (TTM) ₹497.00
EBITDA ₹4.00
Net Income ₹-30.00
Total Assets ₹2,324.00
Total Equity ₹1,001.00

Camlin Fine Sciences Share Price Chart

Track the current stock price of Camlin Fine Sciences with an interactive chart. Analyse CAMLINFINE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Camlin Fine Sciences stock quote in one place.

The quote of ₹71.11 sits between the 52-week low of ₹71.11 and the 52-week high of ₹177.37, and the latest session moved -1.44% from the previous close.

Camlin Fine Sciences Company Profile - Fundamental Screener

Screen Camlin Fine Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CAMLINFINE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Chemicals & Petrochemicals industry, and it trades under ISIN INE052I01032.

Company Details

Classification

Sector Chemicals
Industry Chemicals & Petrochemicals
Sub-Sector Chemicals & Petrochemicals
Segment E

Identifiers and Leadership

ISIN INE052I01032

Camlin Fine Sciences Balance Sheet Screener

Screen CAMLINFINE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,324, up from ₹2,024 in 2025.

Latest statistics put total assets at ₹2,324 and shareholder funds at ₹1,001, with a leverage ratio of 0.71.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 2,324 2,024 1,952 2,060 1,800 1,482 1,234 1,087 1,017 673
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 887 704 816 858 601 584 306 272 278 201

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 349 303 363 443 440 291 226 196 112 57
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,001 875 857 824 765 713 460 430 433 230
Share Capital 19 19 17 16 16 13 12 12 12 10
Reserves & Surplus 1,018 880 845 800 729 582 388 335 359 202

Camlin Fine Sciences Income Statement Screener - Profit & Revenue Analysis

Screen Camlin Fine Sciences income statement and profit fundamentals. Analyze CAMLINFINE quarterly results. Camlin Fine Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹497 and net profit was ₹-30, equal to earnings per unit of ₹-1.45.

In that period expenses were ₹493, interest cost ₹21 and tax ₹-7. The next period listed, 2026-Jun, shows revenue of ₹523 and net profit of ₹-34.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 497 523 535 443 455 415 445 382 383 429 432 429 426 408 388
Expenses 493 524 412 447 428 395 405 446 368 529 384 393 381 381 363

Operating Costs and Margins

EBITDA 4 -1 124 -4 27 20 40 -64 14 -100 48 36 45 27 25
Operating Profit % 0.00% -1.00% 3.00% -1.00% 5.00% 3.00% 6.00% -19.00% 3.00% -27.00% 11.00% 8.00% 9.00% 6.00% 6.00%
Depreciation 20 19 21 16 18 16 17 13 15 17 15 18 19 19 21
Interest 21 14 23 17 18 15 15 16 23 26 34 10 10 20 14

Profit and Earnings

Profit Before Tax -37 -34 80 -37 -9 -11 8 -94 -24 -142 0 8 16 -12 -10
Tax -7 -1 -6 0 6 0 8 -12 11 -26 7 5 4 9 5
Net Profit -30 -34 86 -37 -15 -11 0 -82 -35 -116 -8 4 12 -21 -14
EPS -1.45 -1.65 4.59 -2.38 -0.76 -0.53 -1.25 -4.64 -2.00 -5.88 -0.71 0.59 0.96 -1.17 -0.71

Camlin Fine Sciences Cash Flow Screener - Liquidity Fundamentals

Screen CAMLINFINE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹82, and net cash flow was an inflow of ₹5.

Over the same period, investing activities used ₹53 and financing activities used ₹25.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 82 23 139 51 145 117 86 -9 -15 -9
Investing Activities -53 -75 -67 -125 -249 -133 -90 -2 -149 -70

Financing and Net Cash

Financing Activities -25 76 -86 60 136 39 3 26 182 91
Net Cash Flow 5 24 -14 -14 32 23 -1 15 18 13

Camlin Fine Sciences Shareholding Pattern Screener

See Camlin Fine Sciences shareholding pattern with promoter, FII, and DII holdings. Check Camlin Fine Sciences promoter holding and ownership changes for CAMLINFINE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 48.03%, foreign institutions 0.94%, domestic institutions 7.70% and the public 28.28%, spread across 52,232 shareholders.

The shareholder count was 52,232 in 2026-Mar, compared with 55,178 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Jan 2025-Mar 2025-Jun 2025-Sept 2025-Nov

Promoter Holding

Promoter Holding 48.03% 48.03% 48.03% 49.10% 49.10% 49.10% 49.08% 48.03%

Institutional Investors

FII Holding 0.94% 0.91% 0.95% 0.82% 1.47% 2.88% 2.12% 2.15%
DII Holding 7.70% 5.42% 5.32% 4.09% 3.83% 4.14% 5.48% 7.78%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.28% 29.43% 30.76% 33.14% 32.85% 30.98% 29.20% 26.89%
Other Holding 15.05% 16.21% 14.94% 12.85% 12.75% 12.89% 14.13% 15.15%
Shareholder Count 52,232 55,178 56,981 60,554 58,111 59,538 57,661 52,845

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Camlin Fine Sciences. Camlin Fine Sciences dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Camlin Fine Sciences Stock Index Membership - Nifty & Sensex

See which indices include Camlin Fine Sciences stock. Check CAMLINFINE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP

Camlin Fine Sciences Market Events Screener - Corporate Actions

Get Camlin Fine Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Camlin Fine Sciences stock events that may affect CAMLINFINE share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.

It is followed by Quarterly Result Announcement dated August 11, 2026 and Annual General Meeting dated August 11, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-03 2026-11-03 Quarterly Result Announcement NA 5.46%
2026-08-11 2026-08-11 Quarterly Result Announcement NA -3.04%
2026-08-11 2026-08-11 Annual General Meeting NA 1.30%
2026-05-26 2026-05-26 Quarterly Result Announcement NA -0.97%
2026-02-13 2026-02-13 Quarterly Result Announcement NA -3.72%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 0.05%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -8.63%
2025-08-08 2025-08-08 Annual General Meeting NA 26.19%
2025-05-23 2025-05-23 Quarterly Result Announcement NA 9.49%
2025-02-14 2025-02-14 Quarterly Result Announcement NA 5.94%
2025-01-08 2025-01-08 Rights 5:41 -2.16%
2024-11-11 2024-11-11 Quarterly Result Announcement NA 16.05%
2024-07-31 2024-07-31 Annual General Meeting NA 19.06%

Camlin Fine Sciences Competitors Screener - Peer Stocks Comparison

Screen CAMLINFINE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Solar Industries 170,302 74.20 9,966 30.94% 1,737 44.89
Pidilite Industries 157,344 57.30 14,867 11.05% 2,471 53.93
SRF 73,424 32.10 15,894 7.20% 1,835 54.24
Linde 58,944 118.20 2,549 -0.17% 549 70.98
Gujarat Fluorochemicals 52,993 78.30 5,126 5.63% 574 63.06
Navin Fluorine International 50,728 56.50 3,379 41.21% 664 72.16
Himadri Speciality Chemical 27,633 32.90 4,832 3.60% 755 40.00
Deepak Nitrite 21,753 20.50 7,947 -5.01% 551 55.44
Aether Industries 21,664 89.20 1,181 34.17% 220 53.10
Aarti Industries 17,205 29.50 8,291 13.78% 419 55.19

Camlin Fine Sciences Company Announcements - News & Reports Screener

Screen CAMLINFINE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 17, 2026 and November 13, 2026.

Date Update Actions
2026-11-17 Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. -
2026-11-17 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-11-13 Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. -
2026-11-13 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-11-10 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-03 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-03 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-03 Board Meeting Outcome for Outcome Of Board Meeting -
2026-11-03 Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2026. -
2026-10-30 Announcement Under Regulation 30 SEBI (LODR) Regulations - Receipt Of SEBI Administrative Warning Letter -
2026-10-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-29 Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidate Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026 And The Proposal For Raising Of Funds By Way Of Rights Issue Of Equ -
2026-10-29 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011 -
2026-10-18 Announcement under Regulation 30 (LODR)-Change in Management -
2026-10-16 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-10-16 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-10-16 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-10-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-24 Closure of Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹71.11, within a 52-week range of ₹71.11 to ₹177.37. The P/E ratio is -103.90 and the P/B ratio is 1.52, with earnings per unit of ₹1.46. Market capitalisation stands at ₹1,440.34 Cr. The company operates in the Chemicals sector, in the Chemicals & Petrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.